We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AKZOF market cap is 10.43B. The company's latest EPS is EUR 2.5594 and P/E is 21.67.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 9.28B | 8.53B | 9.59B | 10.85B | 10.67B |
| Operating Income | 861M | 988M | 1.14B | 726M | 1.06B |
| Net Income | 539M | 630M | 829M | 352M | 442M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 12.98B | 13.18B | 13.88B | 14.74B | 14.56B |
| Total Liabilities | 6.42B | 7.23B | 8.24B | 10.19B | 10.01B |
| Total Equity | 6.57B | 5.95B | 5.64B | 4.55B | 4.55B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 23M | 1.22B | 605M | 263M | 1.13B |
| Investing | 5.01B | -427M | -134M | -1.1B | -144M |
| Financing | -6.58B | -353M | -974M | 1.14B | -827M |
| Market Cap | 10.43B |
| Price to Earnings Ratio | 21.67 |
| Price to Sales Ratio | 0.9 |
| Price to Cash Ratio | 6.58 |
| Price to Book Ratio | 2.11 |
| Dividend Yield | 0.69% |
| Shares Outstanding | 172.7M |
| Average Volume (1 week) | 408 |
| Average Volume (1 Month) | 409 |
| 52 Week Change | -19.47% |
| 52 Week High | 80.91 |
| 52 Week Low | 57.46 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Akzo Nobel NV (QX) |
| Address |
christian neefestraat 2 amsterdam, north holland 1070 AS |
| Website | https://www.akzonobel.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
